Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Open Studies | Type 1 Diabetes | Denmark
Show Display Options
Rank Status Study
1 Recruiting Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Dapagliflozin;   Drug: Placebo for Dapagliflozin
2 Recruiting Empagliflozin as Adjunctive to inSulin thErapy in Type 1 Diabetes Over 52 Weeks (EASE-2)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo
3 Recruiting A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: NNC0114-0006;   Drug: liraglutide;   Drug: placebo
4 Recruiting Evaluation of the Hypoglycaemia Alarm Device Hyposafe H02
Condition: Diabetes Mellitus, Type 1
Intervention: Device: hyposafe H02
5 Recruiting Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: Low carbohydrate diet;   Other: High carbohydrate diet
6 Recruiting The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Glucagon before exercise;   Drug: Glucagon after exercise;   Drug: Glucagon after resting
7 Unknown  Liraglutide in Newly Onset Type 1 Diabetes.
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Liraglutide
8 Recruiting The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes
Conditions: Hypoglycemia;   Diabetes Mellitus, Type 1
Interventions: Dietary Supplement: Alcohol;   Dietary Supplement: Placebo
9 Recruiting Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy;   Hereditary Axonal Neuropathy;   Hereditary Demyelinated Neuropathy;   Polyneuropathy, Inflammatory Demyelinating, Chronic
10 Not yet recruiting DiaCon Dual-Hormone Closed-Loop Glucose Control
Condition: Type 1 Diabetes
Interventions: Device: DiaCon dual-hormone closed-loop glucose control algorithm;   Device: DiaCon single-hormone closed-loop glucose control algorithm
11 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
12 Not yet recruiting Acute Exercise and Glucotoxicity
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Interventions: Behavioral: Exercise;   Procedure: Hyperglycemia
13 Recruiting Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes
Conditions: Hypoglycemia;   Breastfeeding
Intervention: Device: Continuous glucose monitoring (CGM)
14 Recruiting Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Intervention: Other: No treatment given
15 Recruiting Volumetric Measurements of Diabetic Foot Ulcers
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Foot
Intervention: Device: 3D photooptical camera
16 Recruiting Diameter Changes of Retinal Vessels During Hypoxia
Conditions: Diabetes Mellitus Type 1;   Diabetic Maculopathy
Interventions: Other: COX inhibitor;   Other: L-NG-monomethyl arginine citrate;   Other: COX inhibitor + L-NG-monomethyl arginine citrate
17 Unknown  Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
Conditions: Diabetes Mellitus Type I;   Diabetes Mellitus Type II
Intervention: Device: Integrated sensor and infusion set.
18 Recruiting Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (U300);   Drug: Insulin degludec;   Drug: GLP-1 receptor agonist;   Drug: Glimepiride;   Drug: Metformin
19 Recruiting Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Sevelamer;   Drug: Cholecystokinin;   Drug: Sevelamer placebo;   Drug: Isotonic saline
20 Recruiting Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Isotonic saline;   Drug: Metformin placebo;   Drug: Cholecystokinin;   Drug: Metformin

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years